Quantification of biological range uncertainties in patients treated at the Krakow proton therapy centre
Open Access
- 9 March 2022
- journal article
- research article
- Published by Springer Nature in Radiation Oncology
- Vol. 17 (1) , 1-13
Abstract
Background: Variable relative biological effectiveness (vRBE) in proton therapy might significantly modify the prediction of RBE-weighted dose delivered to a patient during proton therapy. In this study we will present a method to quantify the biological range extension of the proton beam, which results from the application of vRBE approach in RBE-weighted dose calculation. Methods and materials: The treatment plans of 95 patients (brain and skull base patients) were used for RBE-weighted dose calculation with constant and the McNamara RBE model. For this purpose the Monte Carlo tool FRED was used. The RBE-weighted dose distributions were analysed using indices from dose-volume histograms. We used the volumes receiving at least 95% of the prescribed dose (V95) to estimate the biological range extension resulting from vRBE approach. Results: The vRBE model shows higher median value of relative deposited dose and D95 in the planning target volume by around 1% for brain patients and 4% for skull base patients. The maximum doses in organs at risk calculated with vRBE was up to 14 Gy above dose limit. The mean biological range extension was greater than 0.4 cm. Discussion: Our method of estimation of biological range extension is insensitive for dose inhomogeneities and can be easily used for different proton plans with intensity-modulated proton therapy (IMPT) optimization. Using volumes instead of dose profiles, which is the common method, is more universal. However it was tested only for IMPT plans on fields arranged around the tumor area. Conclusions: Adopting a vRBE model results in an increase in dose and an extension of the beam range, which is especially disadvantageous in cancers close to organs at risk. Our results support the need to re-optimization of proton treatment plans when considering vRBE.Keywords
Funding Information
- Narodowe Centrum Badań i Rozwoju (POWR.03.02.00-00-I013/16)
- Fundacja na rzecz Nauki Polskiej (POIR.04.04.00-00-2475/16-00)
This publication has 39 references indexed in Scilit:
- Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transferPhysics in Medicine & Biology, 2014
- A review of the use and potential of the GATE Monte Carlo simulation code for radiation therapy and dosimetry applicationsMedical Physics, 2014
- Proton therapy for the treatment of children with CNS malignanciesCNS Oncology, 2014
- Experimental validation of the TOPAS Monte Carlo system for passive scattering proton therapyMedical Physics, 2013
- Physical and biological factors determining the effective proton rangeMedical Physics, 2013
- TOPAS: An innovative proton Monte Carlo platform for research and clinical applicationsMedical Physics, 2012
- Range uncertainty in proton therapy due to variable biological effectivenessPhysics in Medicine & Biology, 2012
- Proton therapy for head and neck cancer: Rationale, potential indications, practical considerations, and current clinical evidenceActa Oncologica, 2011
- Computation of cell survival in heavy ion beams for therapyRadiation and Environmental Biophysics, 1997
- Individual Comparisons by Ranking MethodsBiometrics Bulletin, 1945